JACOBS LEVY EQUITY MANAGEMENT, INC - ALEXZA PHARMACEUTICALS INC ownership

ALEXZA PHARMACEUTICALS INC's ticker is ALXA and the CUSIP is 015384209. A total of 22 filers reported holding ALEXZA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 3.8%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of ALEXZA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$109,000
+2.8%
52,753
+128.4%
0.00%0.0%
Q2 2014$106,000
+92.7%
23,100
+84.8%
0.00%
+100.0%
Q1 2014$55,00012,5000.00%
Other shareholders
ALEXZA PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
LANSDOWNE PARTNERS AUSTRIA GMBH 1,212,555$5,262,000100.00%
HOWARD HUGHES MEDICAL INSTITUTE 98,914$429,0000.14%
Rotella Capital Management, Inc. 10,000$43,0000.14%
BBT Capital Management, LLC 132,533$575,0000.03%
Jefferies Group LLC 477,500$2,072,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 246,473$1,070,0000.02%
LANSDOWNE PARTNERS LIMITED PARTNERSHIP 307,500$1,335,0000.02%
FEDERATED HERMES, INC. 674,300$2,926,0000.01%
KNIGHT CAPITAL GROUP LLC 61,466$265,0000.01%
CREDIT SUISSE AG/ 654,292$2,839,0000.00%
View complete list of ALEXZA PHARMACEUTICALS INC shareholders